Purple Biotech Ltd (TLV:PPBT)
Israel · Delayed Price · Currency is ILS · Price in ILA 4.200
0.00 (0.00%)
Jul 17, 2025, 3:33 PM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 23.28 million as of July 18, 2025. Its market cap has decreased by -57.56% in one year.
Market Cap
23.28M
Enterprise Value
-2.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.20
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 23.28M, an increase of 30.24%. That is a compound annual growth rate of 2.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 61.63B |
| Danel (Adir Yeoshua) | 2.90B |
| Kamada | 1.47B |
| Bait Bakfar | 1.07B |
| SofWave Medical | 841.86M |
| BrainsWay | 766.86M |
| Novolog (Pharm-Up 1966) | 717.73M |
| Ilex Medical | 662.22M |